DIRS.INFO The most relevant business & tech news

Shark NeverChange Air Purifier Max The Shark NeverChange Air Purifier Max is a powerful air-cleaning machine for large spaces, and the best part is that you only need to change its filter every five years. Camryn Rabideau/Business InsiderThe Shark NeverChange Air Purifier Max took less than 5 minutes to unbox and get running. Our review of the Shark NeverChange™ Air Purifier MAXAdvertisementEase of UseThe air purifier’s display screen shows the real-time air quality in your home. AdvertisementThe bottom lineFor large spaces, the Shark NeverChange Air Purifier Max is worth the investment. Camryn Rabideau/Business InsiderThe Shark NeverChange Air Purifier Max is a worthwhile option that requires minimal maintenance and covers large rooms.

Persons: Max, Camryn, Philip M, Tierno Jr, Tierno, it's, There's Organizations: Business, Shop, Energy, Stratos, NYU Grossman School of Medicine, NYU Langone Medical, Honeywell

☆ Thomas H. Lee, pioneer of leveraged buyouts, is dead at 78
▼ + stars: | 2023-02-24 | by ( Chris Isidore | ) edition.cnn.com time to read: +3 min

New York CNN —Thomas H. Lee, a private equity financier who pioneered the use of leveraged buyouts that helped to reshape corporate America, has passed away, according to a notice from his former firm that still bears his name. “We are profoundly saddened by the unexpected passing of our good friend and former partner, Thomas H. Lee,” said THL in a statement. “Tom was an iconic figure in private equity. One of Thomas Lee’s most famous, and lucrative, leveraged buyouts was his purchase of Snapple for $135 million in 1992. Lee left THL in 2006 and started another private equity firm, Lee Equity Partners.

A newly approved drug intended to slow the progression of Alzheimer’s disease offers patients hope, but it will come with a steep price tag: $26,500 a year. That drug initially cost $56,000 per year before Biogen slashed the price in half, to $28,000 annually. Dr. David Rind, the institute's chief medical officer, said an appropriate cost for the drug is $8,500 to $20,600 a year. John Domeck, 60, of Aurora, Ohio is currently enrolled in a phase 3 clinical trial testing Leqembi. But right now, the clinical trial for Leqembi shows that the drug provides "modest efficacy at a big, big price," Caplan said.

Pfizer plans to sell the Covid vaccine it developed with BioNTech at $110 to $130 per dose for teens and adults once the U.S. government stops paying for them, the drugmaker said Friday. Since the start of the pandemic, the government has provided Americans with free Covid tests, vaccines and treatment, through a combination of funding from Congress and other government programs. The government has already stopped providing free Covid tests. A CDC advisory committee voted Wednesday to add Covid vaccines to the Vaccines for Children program, a federal plan that provides free vaccines to children eligible for or covered by Medicaid. Pfizer said it also plans to provide free vaccines to people without insurance through its patient assistance program.

☆ The Inflation Reduction Act aims to lower drug costs — but here’s how Big Pharma could get around it
▼ + stars: | 2022-09-20 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Berkeley-Lovelace-Jr.Jpg | Berkeley Lovelace Jr. | ) www.nbcnews.com time to read: +7 min

The Inflation Reduction Act is set to lower drug prices for millions of people in the United States — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many. The tactics may ultimately threaten the law’s ability to lower drug costs for consumers. Higher prices for new drugsOther experts are concerned about how companies might abuse the inflation rebate rule in the health law. The provision, which takes effect next year, imposes a rebate on drug manufacturers that raise the prices of their medications faster than inflation. By releasing new drugs at higher prices, drug companies will be able to make up for any lost revenue that they would normally receive from steadily raising prices each year, she said.

Search resuls for: "NYU Langone Medical"

5 mentions found